Showing results (291-300 of 560) with videos related to
Sort By:
Pageof 56
The Cochrane Database of Systematic Reviews|May 16, 2018
L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosisEe Teng Goh, Caroline S Stokes, Sandeep S Sidhu, et al.Scientific Reports|November 25, 2020
Species, sex and geographic variation in chlamydial prevalence in abundant wild Australian parrotsHelena S Stokes, Johanne M Martens, Ken Walder, et al.Clinical Science (London, England : 1979)|May 1, 1992
Effects of oral contraceptives containing oestrogen combined with norethisterone or levonorgestrel on erythrocyte cation transport in normal womenG S Stokes, J C Monaghan, C L Flemming, et al.Regulatory Toxicology and Pharmacology : RTP|October 27, 2010
Safety assessment of allergic contact dermatitis hazards: an analysis supporting reduced animal use for the murine local lymph node assayJoseph K Haseman, Judy Strickland, David Allen, et al.American Journal of Obstetrics and Gynecology|July 1, 1991
Daily administration of the progesterone antagonist RU 486 prevents implantation in the cycling guinea pigM C Batista, T L Bristow, J Mathews, et al.Australian and New Zealand Journal of Medicine|February 1, 1976
Diazoxide-induced renin release in diagnosis of remediable renovascular hypertensionG S Stokes, M A Weber, J Gain, et al.Clinical and Experimental Hypertension (New York, N.Y. : 1993)|November 1, 1994
Comparative and combined efficacy of doxazosin and enalapril in hypertensive patientsG S Stokes, H J Johnston, E O Okoro, et al.Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1991
The effects of sulindac and diclofenac in essential hypertension controlled by treatment with a beta blocker and/or diureticG S Stokes, P M Brooks, H J Johnston, et al.Clinical Oncology (Royal College of Radiologists (Great Britain))|August 5, 2020
Spine and Non-spine Bone Metastases - Current Controversies and Future DirectionA Challapalli, S Aziz, V Khoo, et al.British Journal of Cancer|April 14, 2011
Insulin-like growth factor-binding protein-2 promotes prostate cancer cell growth via IGF-dependent or -independent mechanisms and reduces the efficacy of docetaxelC C Uzoh, J M P Holly, K M Biernacka, et al.Pageof 56